Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
PaperCitations, authors & open-access status
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 653 citations, 2020 year and green oa status.
653
Citations
2020
Year
green
OA Status